Based on the Ginkgo Bioworks Holdings stock forecast from 5 analysts, the average analyst target price for Ginkgo Bioworks Holdings is USD 2.15 over the next 12 months. Ginkgo Bioworks Holdings’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Ginkgo Bioworks Holdings is Slightly Bearish, which is based on 3 positive signals and 6 negative signals. At the last closing, Ginkgo Bioworks Holdings’s stock price was USD 0.8428. Ginkgo Bioworks Holdings’s stock price has changed by -11.28% over the past week, -21.23% over the past month and -35.66% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for DNA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
